Annexon, Inc.
INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF

Last updated:

Abstract:

Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.

Status:
Application
Type:

Utility

Filling date:

19 Jul 2021

Issue date:

17 Feb 2022